{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:17:22Z","timestamp":1782015442012,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700402"],"award-info":[{"award-number":["2021YFC2700402"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401265"],"award-info":[{"award-number":["81401265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401267"],"award-info":[{"award-number":["81401267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730041"],"award-info":[{"award-number":["81730041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jri.2022.103674","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T22:59:13Z","timestamp":1658185153000},"page":"103674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A retrospective study on IVF\/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment"],"prefix":"10.1016","volume":"153","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2022.103674_bib1","doi-asserted-by":"crossref","unstructured":"A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid Antibody Committee. 2000. Fertil Steril, 74: 631\u2013634.","DOI":"10.1016\/S0015-0282(00)01525-9"},{"key":"10.1016\/j.jri.2022.103674_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jri.2022.103674_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2017.08.002","article-title":"Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF\/ICSI treatment: a prospective cohort study","volume":"122","author":"Chen","year":"2017","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103674_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2016.01.018","article-title":"The hidden world of anti-phospholipid antibodies and female infertility: a literature appraisal","volume":"15","author":"Chighizola","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jri.2022.103674_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0961203319893763","article-title":"Antiphospholipid syndrome and infertility","volume":"29","author":"El Hasbani","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jri.2022.103674_bib6","first-page":"CD012852","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamulyak","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jri.2022.103674_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5468\/ogs.2018.61.3.359","article-title":"Impact of presence of antiphospholipid antibodies on in vitro fertilization outcome","volume":"61","author":"Hong","year":"2018","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.jri.2022.103674_bib8","first-page":"1","article-title":"In vitro fertilization outcomes in women with antiphospholipid antibodies circulation","author":"Khizroeva","year":"2018","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"10.1016\/j.jri.2022.103674_bib9","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/14767058.2018.1535586","article-title":"In vitro fertilization outcomes in women with antiphospholipid antibodies circulation","volume":"33","author":"Khizroeva","year":"2020","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"10.1016\/j.jri.2022.103674_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1024\/0301-1526\/a000723","article-title":"Antiphospholipid syndrome - an update","volume":"47","author":"Linnemann","year":"2018","journal-title":"Vasa"},{"key":"10.1016\/j.jri.2022.103674_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0041-1729763","article-title":"The pathophysiology of hypercoagulability and infertility","volume":"39","author":"Malinowski","year":"2021","journal-title":"Semin Reprod. Med."},{"key":"10.1016\/j.jri.2022.103674_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.jri.2022.103674_bib13","doi-asserted-by":"crossref","unstructured":"RPL, et al., 2018. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open, 2018: hoy004.","DOI":"10.1093\/hropen\/hoy004"},{"key":"10.1016\/j.jri.2022.103674_bib14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2022.103674_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/09513590.2019.1653564","article-title":"Does subclinical hypothyroidism and\/or thyroid autoimmunity influence the IVF\/ICSI outcome? Review of the literature","volume":"35","author":"Safarian","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.jri.2022.103674_bib16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.fertnstert.2009.08.062","article-title":"Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure","volume":"93","author":"Sauer","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103674_bib17","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/oxfordjournals.humrep.a138437","article-title":"High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin","volume":"9","author":"Sher","year":"1994","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2022.103674_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.thromres.2015.11.026","article-title":"Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function","volume":"137","author":"Shomer","year":"2016","journal-title":"Thromb. Res"},{"key":"10.1016\/j.jri.2022.103674_bib19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1160\/TH12-06-0381","article-title":"Association of common thrombophilias and antiphospholipid antibodies with success rate of in vitro fertilization","volume":"108","author":"Steinvil","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103674_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0015-0282(03)00610-1","article-title":"A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies","volume":"80","author":"Stern","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103674_bib21","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1073\/pnas.90.14.6464","article-title":"Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation","volume":"90","author":"Sthoeger","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jri.2022.103674_bib22","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/oxfordjournals.humrep.a019125","article-title":"Defective maternal-fetal interaction in a murine autoimmune model","volume":"11","author":"Tartakovsky","year":"1996","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2022.103674_bib23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jri.2022.103674_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/humupd\/dmu049","article-title":"Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment","volume":"21","author":"Tong","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jri.2022.103674_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0897.2005.00294.x","article-title":"Anti-phospholipid antibodies against phosphatidylinositol, and phosphatidylserine are more significant in reproductive failure than antibodies against cardiolipin only","volume":"54","author":"Ulcova-Gallova","year":"2005","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103674_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.183.4122.325","article-title":"An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin","volume":"183","author":"Willis","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.jri.2022.103674_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-014-0485-9","article-title":"The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome","volume":"17","author":"Willis","year":"2015","journal-title":"Curr. Rheuma Rep."},{"key":"10.1016\/j.jri.2022.103674_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jri.2012.04.002","article-title":"A retrospective study on IVF outcome in patients with anticardiolipin antibody: effects of methylprednisolone plus low-dose aspirin adjuvant treatment","volume":"94","author":"Ying","year":"2012","journal-title":"J. Reprod. Immunol."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037822002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037822002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:30:08Z","timestamp":1759033808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037822002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":28,"alternative-id":["S0165037822002030"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2022.103674","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective study on IVF\/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2022.103674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103674"}}